Cytogenetic alterations in sorted HSCs and whole bone marrow populations
No. . | MDS IPSS risk group . | Chromosomal abnormality . | Abnormality in HSCs, % . | Abnormality in whole BM, % . |
---|---|---|---|---|
MDS9 | High | −7 | 99 | 48 |
MDS10 | Int-2 | −7 | 76 | 60 |
MDS17 | High | −7 | 100 | 70 |
MDS15 | High | −7q | 100 | 69 |
MDS3 | Int-1 | −5 | 100 | 80 |
MDS5 | Low | −20 | 86 | 57 |
MDS13 | Int-2 | −7q | 81 | 50 |
No. . | MDS IPSS risk group . | Chromosomal abnormality . | Abnormality in HSCs, % . | Abnormality in whole BM, % . |
---|---|---|---|---|
MDS9 | High | −7 | 99 | 48 |
MDS10 | Int-2 | −7 | 76 | 60 |
MDS17 | High | −7 | 100 | 70 |
MDS15 | High | −7q | 100 | 69 |
MDS3 | Int-1 | −5 | 100 | 80 |
MDS5 | Low | −20 | 86 | 57 |
MDS13 | Int-2 | −7q | 81 | 50 |